Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227 Article

Glass, Jon, Won, Minhee, Schultz, Christopher J et al. (2016). Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227 . JOURNAL OF CLINICAL ONCOLOGY, 34(14), 1620-U142. 10.1200/JCO.2015.64.8634

Open Access International Collaboration

cited authors

  • Glass, Jon; Won, Minhee; Schultz, Christopher J; Brat, Daniel; Bartlett, Nancy L; Suh, John H; Werner-Wasik, Maria; Fisher, Barbara Jean; Liepman, Marcia K; Augspurger, Mark; Bokstein, Felix; Bovi, Joseph A; Solhjem, Matthew C; Mehta, Minesh P

sustainable development goals

authors

publication date

  • May 10, 2016

published in

keywords

  • CELL TRANSPLANTATION
  • CYCLOPHOSPHAMIDE
  • DEXAMETHASONE
  • DOXORUBICIN
  • HIGH-DOSE CHEMOTHERAPY
  • Life Sciences & Biomedicine
  • NERVOUS-SYSTEM LYMPHOMA
  • NON-HODGKINS-LYMPHOMA
  • Oncology
  • Science & Technology
  • THERAPY
  • TRIAL
  • VINCRISTINE

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 1620

end page

  • U142

volume

  • 34

issue

  • 14